In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series E raises $39mm for Paradigm Spine

Executive Summary

Paradigm Spine (develops non-fusion spinal implants) raised $39mm in its Series E financing led by returning shareholder HealthCor Partners, which was joined by first-time backer Trevi Health Ventures and individual investors. The company will use the funds for the US launch of its recently approved DSS lumbar vertebrae system and to continue US trials of the coflex device for spinal stenosis.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies